THERAPIX BIOSCIENCES LTD (TRPXY)
Institutional ownership reported to the SEC as of Q2 2020, across 7 quarters.
4
Reporting holders
$312.0K
Reported value
0.0%
Held as options
+1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| MORGAN STANLEY | $271.0K | 436,189 | 0.00% | 11q | +3682.1%+$263.8K |
| UBS Group AG | $26.0K | 41,428 | 0.00% | 4q | +657.9%+$22.6K |
| MILLENNIUM MANAGEMENT LLC | $9.0K | 14,200 | 0.00% | new | NEW |
| ENVESTNET ASSET MANAGEMENT INC | $6.0K | 10,018 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2020 | 4 | $312.0K | 501,835 | 2 | 2 | 0 | 0.0% |
| Q1 2020 | 3 | $11.0K | 27,179 | 1 | 2 | 0 | 0.0% |
| Q4 2019 | 4 | $20.0K | 17,397 | 1 | 1 | 1 | 0.0% |
| Q3 2019 | 4 | $8.5K | 3,371 | 2 | 0 | 1 | 0.0% |
| Q2 2019 | 2 | $26.5K | 10,405 | 0 | 0 | 1 | 0.0% |
| Q1 2019 | 4 | $332.6K | 106,568 | 3 | 0 | 1 | 0.0% |
| Q4 2018 | 4 | $212.0K | 65,340 | 1 | 1 | 0 | 0.0% |